Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells

Molecular Cancer

Volumn 6, Issue , 2007, Pages

  Rao, Sieta P ^a   Rechsteiner, Markus P ^a   Berger, Christoph ^a   Sigrist, Jürg A ^a   Nadal, David ^a   Bernasconi, Michele ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; B LYMPHOCYTE RECEPTOR; DNA METHYLTRANSFERASE INHIBITOR; MESSENGER RNA; PROTEIN EBNA2; PROTEIN LMP2A; PROTEIN LMP2B; UNCLASSIFIED DRUG; UVOMORULIN; VIRUS PROTEIN; ZEBULARINE;

ARTICLE; BURKITT LYMPHOMA; CANCER THERAPY; CONTROLLED STUDY; CROSS LINKING; DNA METHYLATION; DRUG SAFETY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOMA CELL; LYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; UPREGULATION; VIRUS CARRIER; VIRUS INFECTION; VIRUS LATENCY;

ANTINEOPLASTIC AGENTS; AZACITIDINE; BURKITT LYMPHOMA; CADHERINS; CYTIDINE; GENE SILENCING; HERPESVIRUS 4, HUMAN; HUMANS; TUMOR CELLS, CULTURED; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

EID: 33846796029     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-6-3     Document Type: Article

References (30)

1. Esteller M DNA methylation and cancer therapy: New developments and expectations Curr Opin Oncol 2005 17 1 55-60 10.1097/ 01.cco.0000147383.04709.10 15608514
2. Silverman LR Demakos EP Peterson BL Kornblith AB Holland JC Odchimar-Reissig R Stone RM Nelson D Powell BL DeCastro CM Ellerton J Larson RA Schiffer CA Holland JF Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B J Clin Oncol 2002 20 10 2429-2440 10.1200/JCO.2002.04.117 12011120
3. Christman JK 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: Mechanistic studies and their implications for cancer therapy Oncogene 2002 21 35 5483-5495 10.1038/ sj.onc.1205699 12154409
4. Cihak A Biological effects of 5-azacytidine in eukaryotes Oncology 1974 30 5 405-422 4142650
5. Notari RE DeYoung JL Kinetics and mechanisms of degradation of the antileukemic agent 5-azacytidine in aqueous solutions J Pharm Sci 1975 64 7 1148-1157 10.1002/jps.2600640704 50433
6. Kissinger LD Stemm NL Determination of the antileukemia agents cytarabine and azacitidine and their respective degradation products by high-performance liquid chromatography J Chromatogr 1986 353 309-318 10.1016/S0021-9673(01)87101-6 2422189
7. Cohen JI Epstein-Barr virus infection N Engl J Med 2000 343 7 481-492 10.1056/NEJM200008173430707 10944566
8. Ben-Sasson SA Klein G Activation of the Epstein-Barr virus genome by 5-aza-cytidine in latently infected human lymphoid lines Int J Cancer 1981 28 2 131-135 6172387
9. Ernberg I Falk K Minarovits J Busson P Tursz T Masucci MG Klein G The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus J Gen Virol 1989 70 2989-3002 2479717
10. Masucci MG Contreras-Salazar B Ragnar E Falk K Minarovits J Ernberg I Klein G 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael J Virol 1989 63 7 3135-3141 250871 2470924
11. Jansson A Masucci M Rymo L Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines J Virol 1992 66 1 62-69 238260 1370095
12. Chan AT Tao Q Robertson KD Flinn IW Mann RB Klencke B Kwan WH Leung TW Johnson PJ Ambinder RF Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors J Clin Oncol 2004 22 8 1373-1381 10.1200/JCO.2004.04.185 15007085
13. Feng WH Cohen JI Fischer S Li L Sneller M Goldbach-Mansky R Raab-Traub N Delecluse HJ Kenney SC Reactivation of latent Epstein-Barr virus by methotrexate: A potential contributor to methotrexate-associated lymphomas J Natl Cancer Inst 2004 96 22 1691-1702 15547182
14. Hurd PJ Whitmarsh AJ Baldwin GS Kelly SM Waltho JP Price NC Connolly BA Hornby DP Mechanism-based inhibition of C5-cytosine DNA methyltransferases by 2-H pyrimidinone J Mol Biol 1999 286 2 389-401 10.1006/jmbi.1998.2491 9973559
15. Kim CH Marquez VE Mao DT Haines DR McCormack JJ Synthesis of pyrimidin-2-one nucleosides as acid-stable inhibitors of cytidine deaminase J Med Chem 1986 29 8 1374-1380 10.1021/jm00158a009 3735306
16. Cheng JC Matsen CB Gonzales FA Ye W Greer S Marquez VE Jones PA Selker EU Inhibition of DNA methylation and reactivation of silenced genes by zebularine J Natl Cancer Inst 2003 95 5 399-409 12618505
17. Zhou L Cheng X Connolly BA Dickman MJ Hurd PJ Hornby DP Zebularine: A novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases J Mol Biol 2002 321 4 591-599 10.1016/ S0022-2836(02)00676-9 12206775
18. Cheng JC Yoo CB Weisenberger DJ Chuang J Wozniak C Liang G Marquez VE Greer S Orntoft TF Thykjaer T Jones PA Preferential response of cancer cells to zebularine Cancer Cell 2004 6 2 151-158 10.1016/ j.ccr.2004.06.023 15324698
19. Lemaire M Momparler LF Bernstein ML Marquez VE Momparler RL Enhancement of antineoplastic action of 5-aza-2′-deoxycytidine by zebularine on L1210 leukemia Anticancer Drugs 2005 16 3 301-308 10.1097/ 00001813-200503000-00009 15711182
20. Wiman KG Magnusson KP Ramqvist T Klein G Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240 Oncogene 1991 6 9 1633-1639 1923530
21. Strathdee G Epigenetic versus genetic alterations in the inactivation of E-cadherin Semin Cancer Biol 2002 12 5 373-379 10.1016/ S1044-579X(02)00057-3 12191636
22. Auerkari EI Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis Oral Oncol 2006 42 1 5-13 10.1016/ j.oraloncology.2005.03.016 15978859
23. Shaker S Bernstein M Momparler RL Antineoplastic action of 5-aza-2′-deoxycytidine (Dacogen) and depsipeptide on Raji lymphoma cells Oncol Rep 2004 11 6 1253-1256 15138563
24. Stresemann C Brueckner B Musch T Stopper H Lyko F Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines Cancer Res 2006 66 5 2794-2800 10.1158/0008-5472.CAN-05-2821 16510601
25. Corn PG Smith BD Ruckdeschel ES Douglas D Baylin SB Herman JG E-cadherin expression is silenced by 5′ CpG island methylation in acute leukemia Clin Cancer Res 2000 6 11 4243-4248 11106238
26. Packham G Economou A Rooney CM Rowe DT Farrell PJ Structure and function of the Epstein-Barr virus BZLF1 protein J Virol 1990 64 5 2110-2116 249368 2157874
27. Bernasconi M Berger C Sigrist JA Bonanomi A Sobek J Niggli FK Nadal D Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray Virol J 2006 3 43 1533810 16756670 10.1186/1743-422X-3-43
28. Yuan J Cahir-McFarland E Zhao B Kieff E Virus and cell RNAs expressed during Epstein-Barr virus replication J Virol 2006 80 5 2548-2565 1395376 16474161 10.1128/JVI.80.5.2548-2565.2006
29. Tsai CN Tsai CL Tse KP Chang HY Chang YS The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases Proc Natl Acad Sci U S A 2002 99 15 10084-10089 126628 12110730 10.1073/ pnas.152059399
30. Bonanomi A Kojic D Giger B Rickenbach Z Jean-Richard-Dit-Bressel L Berger C Niggli FK Nadal D Quantitative cytokine gene expression in human tonsils at excision and during histoculture assessed by standardized and calibrated real-time PCR and novel data processing J Immunol Methods 2003 283 1-2 27-43 10.1016/j.jim.2003.08.002 14659897